Lazard Asset Management
ASPX

Lazard Asset Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Lazard Asset Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-64,135
Closed -$6.43M – 1228
2015
Q1 		$6.43M Sell
64,135
-52,725
-45% -$3.51M 0.01% 486
2014
Q4 		$6.13M Buy
+116,860
New +$3.43M 0.01% 504

Lazard Asset Management's ASPX Position: Q2 2015 in Review

Lazard Asset Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 64,135 shares — an estimated $6.43M sold.

Lazard Asset Management first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $6.43M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Lazard Asset Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Lazard Asset Management sold 64,135 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $6.43M.
  • Lazard Asset Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Lazard Asset Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $6.43M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Lazard Asset Management's 13F filing for Q2 2015, filed 13 Aug 2015.